How do you take a scientific hunch and turn it into a breakthrough that could change medicine forever?
In this episode of Wild Hearts, we sit down with Elise Jenkins, co-founder of Opto Biosystems, to discuss the journey of building a first-in-class brain implant that merges neurotechnology with oncology.
🎧 Subscribe on Apple or Spotify to learn.
We explore the highs and lows of moving from academia to a high-stakes startup, the unexpected hurdles of working with neurosurgeons, and the race toward first-in-human trials.
In this conversation, we cover:
🧠 Bridging the gap between neuroscience and cancer research
🔬 How brain-Computer interfaces could transform oncology
📈 The road to the first-in-human clinical trials and what It means for the future
💡 The challenges of moving from academia to a high-impact startup
⚡ Why the next generation of neural implants need to be MRI-invisible
🏥 What It takes to get regulatory approval for a revolutionary medical implant
🌎 Opto’s long-term vision: using neural biomarkers beyond brain cancer
If you're fascinated by the intersection of science, engineering, and medicine, this conversation is for you.
🎧 Subscribe on Apple or Spotify to learn.